Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

MKSAP: 69-year-old woman with new-onset dependent edema

mksap
Conditions
August 3, 2019
Share
Tweet
Share

Test your medicine knowledge with the MKSAP challenge, in partnership with the American College of Physicians.

A 69-year-old woman is evaluated in the emergency department for new-onset dependent edema that began 3 weeks ago. She says it is difficult to walk, and she has gained 4.5 kg (10 lb) of fluid weight. History is significant for obesity and hypertension. Her only medication is lisinopril.

On physical examination, vital signs are normal. BMI is 32. There is no rash. There is 3-mm bilateral dependent edema stopping just below the abdomen; it is equal on both sides. The remainder of the examination is unremarkable.

Laboratory studies:

Albumin 2.1 g/dL (21 g/L)
Creatinine 1.3 mg/dL (114.9 µmol/L)
Urine protein-creatinine ratio 8700 mg/g

Kidney biopsy findings are consistent with a diagnosis of minimal change glomerulopathy with superimposed acute tubular necrosis.

In addition to initiating diuretic therapy, which of the following is the most appropriate treatment?

A. Cyclosporine
B. High-dose oral prednisone
C. Rituximab
D. No additional treatment

MKSAP Answer and Critique

The correct answer is B. High-dose oral prednisone.

Diuretics plus high-dose prednisone is the most appropriate treatment for this patient with minimal change glomerulopathy (MCG; also known as minimal change disease). MCG is the most common cause of the nephrotic syndrome in children and accounts for approximately 10% to 15% of cases in adults. Immunosuppressive therapy is indicated for treatment of primary MCG, which invariably presents with the full nephrotic syndrome. The concomitant acute tubular necrosis makes treatment even more imperative in this case, because primary MCG with acute kidney injury has been shown to be a treatment-responsive lesion if treated in a timely manner. First-line therapy is prednisone at a dose of 1 mg/kg per day or 2 mg/kg every other day for 8 to 12 weeks, followed by a taper. Patients typically respond to glucocorticoids within 8 to 16 weeks. However, relapse is common, and in a substantial percentage of patients, the course of MCG is one of remission followed by relapse. For frequently relapsing or glucocorticoid-dependent disease, treatment options include cyclophosphamide, calcineurin inhibitors (tacrolimus or cyclosporine), mycophenolate mofetil, and rituximab. In addition to immunosuppression, patients should receive standard therapy for the nephrotic syndrome, including an ACE inhibitor or angiotensin receptor blocker (this patient is already taking lisinopril, with well-controlled blood pressure), diuretics for edema management, and cholesterol-lowering medication if total cholesterol >200 mg/dL (5.1 mmol/L). In rare cases of MCG secondary to malignancies (Hodgkin lymphoma, non-Hodgkin lymphoma, thymoma), medications (NSAIDs, lithium), infections (strongyloides, syphilis, mycoplasma, ehrlichiosis), and atopy (pollen, dairy products), treatment of the underlying condition without immunosuppression may be sufficient.

Cyclosporine and rituximab are generally reserved for glucocorticoid-resistant or glucocorticoid-dependent cases of MCG and, except for a clear contraindication to glucocorticoids, should not be used as first-line therapy.

Diuretics alone are not sufficient to manage this patient and prevent progressive kidney disease; immunosuppressive therapy is therefore indicated.

Key Point

  • Glucocorticoids are first-line therapy for primary minimal change glomerulopathy; standard treatment of the nephrotic syndrome (ACE inhibitor or angiotensin receptor blocker, diuretics for edema, and cholesterol-lowering medication if total cholesterol >200 mg/dL [5.1 mmol/L]) is also indicated as needed.

This content is excerpted from MKSAP 18 with permission from the American College of Physicians (ACP). Use is restricted in the same manner as that defined in the MKSAP 18 Digital license agreement. This material should never be used as a substitute for clinical judgment and does not represent an official position of ACP. All content is licensed to KevinMD.com on an “AS IS” basis without any warranty of any nature. The publisher, ACP, shall no3t be liable for any damage or loss of any kind arising out of or resulting from use of content, regardless of whether such liability is based in tort, contract or otherwise.

Prev

When should physicians read the House of God?

August 2, 2019 Kevin 5
…
Next

Roundsmanship: the skill you didn't know you needed

August 3, 2019 Kevin 1
…

Tagged as: Nephrology

Post navigation

< Previous Post
When should physicians read the House of God?
Next Post >
Roundsmanship: the skill you didn't know you needed

ADVERTISEMENT

More by mksap

  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 26-year-old man with back pain

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 36-year-old man with abdominal cramping, diarrhea, malaise, and nausea

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 52-year-old woman with osteoarthritis of the right hip

    mksap

Related Posts

  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 35-year-old woman with constipation

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 60-year-old woman with persistent constipation

    mksap
  • a desk with keyboard and ipad with the kevinmd logo

    MKSAP: 45-year-old woman with type 2 diabetes mellitus

    mksap
  • 3 ways we’ve failed woman who breastfeed

    Joanna Buscemi, PhD
  • How one woman prevented a pharmaceutical disaster

    James Essinger and Sandra Koutzenko
  • A skin-lightening cream put a woman into a coma. How can that happen?

    Anna Almendrala

More in Conditions

  • The Cap’n Crunch philosophy of medicine

    Timothy Thomas
  • The surprising link between migraine and tinnitus

    Brian F. Worden, MD
  • Rethinking the JUPITER trial and statin safety

    Larry Kaskel, MD
  • Why culturally compassionate care matters for South Asian communities

    Nishat Uddin, MPH
  • My rare disease was my greatest teacher

    Dr. Palmusima Tamang
  • Reclaiming the human parts of a physician

    Annia Raja, PhD
  • Most Popular

  • Past Week

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The silent disease causing 400 amputations daily

      Xzabia Caliste, MD | Conditions
    • Crypto trading’s impact on mental and physical health

      Dr. Aristomenis Exadaktylos, Dr. Suhaib J. S. Ahmad, and Dr. Thomas Mueller | Conditions
    • The Cap’n Crunch philosophy of medicine

      Timothy Thomas | Conditions
    • A doctor’s duty on 9/11 in a small town

      Ronald L. Lindsay, MD | Physician
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
  • Recent Posts

    • The Cap’n Crunch philosophy of medicine

      Timothy Thomas | Conditions
    • Building the medical home before it had a name

      Ronald L. Lindsay, MD | Physician
    • Why doctors are leaving insurance-based care

      Dana Y. Lujan, MBA | Policy
    • The surprising link between migraine and tinnitus

      Brian F. Worden, MD | Conditions
    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • Why culturally compassionate care matters for South Asian communities

      Nishat Uddin, MPH | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The silent disease causing 400 amputations daily

      Xzabia Caliste, MD | Conditions
    • Crypto trading’s impact on mental and physical health

      Dr. Aristomenis Exadaktylos, Dr. Suhaib J. S. Ahmad, and Dr. Thomas Mueller | Conditions
    • The Cap’n Crunch philosophy of medicine

      Timothy Thomas | Conditions
    • A doctor’s duty on 9/11 in a small town

      Ronald L. Lindsay, MD | Physician
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
  • Recent Posts

    • The Cap’n Crunch philosophy of medicine

      Timothy Thomas | Conditions
    • Building the medical home before it had a name

      Ronald L. Lindsay, MD | Physician
    • Why doctors are leaving insurance-based care

      Dana Y. Lujan, MBA | Policy
    • The surprising link between migraine and tinnitus

      Brian F. Worden, MD | Conditions
    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • Why culturally compassionate care matters for South Asian communities

      Nishat Uddin, MPH | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...